Zusammenfassung
Etwa zwei Drittel der diagnostizierten Patienten mit Diabetes mellitus Typ 2 in den westlichen Industrieländern sind über 60 Jahre alt. Die Prävalenz eines manifesten Diabetes mellitus Typ 2 wird bei über 70-Jährigen mit mehr als 20% angegeben. Nach Untersuchungen in medizinisch betreuten geriatrischen Pflegeheimen wurden bei 50% der Patienten Hinweise auf einen gestörten Glukosestoffwechsel gefunden (Equiluz-Bruck et al. 2001; Hauner et al. 2001; Sinclair et al. 1997).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Beebe KA (1999) Rosiglitazone is effective and well tolerated in patients ≥ 65 years with typ 2 diabetes. Diabetes 48(Suppl 1):0479
Bertoni AG, Krop JS, Anderson GF, Brancati FL (2002) Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care 25:471–475
California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes (2003) Guidelines for improving the care of the older person with diabetes mellitus. JAGS 51:65–280
Donnan PT, MacDonald TM, Morrist AD for the DARTS/MEMO Collaboration (2002) Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabetic Medicine 19:279–284
Egede LE, Zheng D, Simpson K (2002) Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25: 464–470
Equiluz-Bruck S, Liebisch B, Bernecker P, Fasching P (2001) HbA1c — ein geeigneter Screeningparameter für Glukosetoleranzstörung in der Geriatrie. Wien Klin Wochenschr 113: S7
Fasching P (1998) Possible risk of sulphonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease. Diabetologia 41:743–744
Fontbonne A, Berr C, Ducimetiere, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavourably affected in elderly diabetic subjects. Results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370
Gregg EW, Yaffe K, Cauley JA et al for the Study of Osteoporotic Fractures Research Group (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women ? Arch Intern Med 160:174–180
Gregg EW, Beckles GLA, Williamson DF et al (2000) Diabetes and physical disability among older U.S. adults. Diabetes Care 23:1272–1277
Hauner H, Kurnaz AA, Haastert B et al (2001) Undiagnosed diabetes mellitus and metabolic control assessed by HbA1c among residents of nursing homes. Exp Clin Endocrinol Diabetes 109:326–329
Johnston PS, Lebovitz HE, Coniff RF et al (1998) Advantages of alpha-glucosidase inhibition as monotherapy in elderly Type 2 diabetic patients. J Clin Endocrinol Metab 83: 1515–1522
Koivisto VA, Tuominen JA, Ebeling P (1999) Lispro Mix 25 insulin as premeal therapy in type 2 diabetic patients. Diabetes Care 22:459–462
Krop JS, Powe NR, Weiler WE et al (1998) Patterns of expenditures and use of services among older adults with diabetes. Diabetes Care 21:747–752
Ott A, Stolk RP, van Harskamp F et al (1999) Diabetes mellitus and the risk of dementia. The Rotterdam study. Neurology 53:1937–1942
Perry RC, Shankar RR, Fineberg N et al (2001) HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose. The early diabetes intervention program (EDIP). Diabetes Care 24:465–471
Rosenthal MJ, Fajardo M, Gilmore S et al (1998) Hospitalisation and mortality of diabetes in older adults. Diabetes Care 21: 231–235
Sinclair AJ, Robert IE, Croxson SCM (1997) Mortality in older people with diabetes mellitus. Diabetic Med 14:639–647
Sinclair AJ, Gadsby R, Penfold S et al (2001) Prevalence of diabetes in care home residents. Diabetes Care 24:1066–1068
Sinclair AJ (2001) New approaches to treatment of the elderly with diabetes. Pract Diab lnt 18:4, S11-S12
Tariot PN, Ogden MA, Cox C, Williams TF (1999) Diabetes and dementia in long-term care. J Am Geriatr Soc 47:423–429
Tuomilehto J for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators (1999) Effect of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 340:677–684
UK Prospective Diabetes Study (UKPDS) Group, UKPDS 33 (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:854–865
Van Staa T, Abenhaim L, Monette J (1997) Rates of hypoglycaemia in users of sulfonylureas. J Clin Epidemiol 50:735–741
Wolffenbüttel BHR, Landgraf R on behalf of the Dutch and German Repaglinide Study Group (1999) A 1-year multi-center randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Diabetes Care 22:463–467
Zeyfang A, Feucht I, Fetzer G et al (2001) Eine strukturierte geriatrische Diabetiker-Schulung (SGS) ist sinnvoll. Diabetes und Stoffwechsel 10:203–207
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fasching, P. (2004). Diabetes im hohen Lebensalter. In: Waldhäusl, W.K., Gries, F.A., Scherbaum, W.A. (eds) Diabetes in der Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18571-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-18571-7_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62166-6
Online ISBN: 978-3-642-18571-7
eBook Packages: Springer Book Archive